Zeo ScientifiXZEOX 52 Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus rates ZEOX with a GF Score™ of 52/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 146 Biotechnology companies, Zeo ScientifiX ranks worse than 684930.82% on this metric.
As of today (2026-06-27), the Forward Annual Dividend Yield of Zeo ScientifiX is 0.00%.
As of today (2026-06-27), the Trailing Annual Dividend Yield of Zeo ScientifiX is 0.00%.
ZEOX's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.525 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Zeo ScientifiX Forward Dividend Yield % Related Terms
ZEOX vs LNAI, GDTC, HOOK: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Zeo ScientifiX's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Zeo ScientifiX (ZEOX) has a Forward Dividend Yield % of 0.00% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zeo ScientifiX and its competitors. According to the industry distribution chart, Zeo ScientifiX ranks #999999 out of 146 companies in the Biotechnology industry.
Is Zeo ScientifiX's Forward Dividend Yield % too high?
Zeo ScientifiX's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Zeo ScientifiX ranks #999999 out of 146 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zeo ScientifiX has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's Forward Dividend Yield % compare to LNAI and GDTC?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #999999 out of 146 companies for Forward Dividend Yield %. This places Zeo ScientifiX in the lower half of its industry. The industry median Forward Dividend Yield % is 1.53. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.53, based on 146 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Zeo ScientifiX and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zeo ScientifiX's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.75 — trading 34.5% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Zeo ScientifiX's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zeo ScientifiX (ZEOX) Overvalued in 2026?
Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued.
The current stock price of $1.75 is trading 34.5% below its estimated GF Value™ of $2.67.
GuruFocus considers Zeo ScientifiX to be Possible Value Trap.
Key valuation signals for ZEOX:
Forward Dividend Yield %: 0.00%
GF Value™: $2.67 vs. price of $1.75 (34.5% below fair value)
No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
52GF Score
Get the complete analysis for ZEOX
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZEOX has been successfully added to your 